Max P Kristiansen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

High Fat Diet Induced

Optical Coherence Tomography

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Anja W Olsen, Ida Rosenkrands, Christina S Jacobsen, Hannah M Cheeseman, Max P Kristiansen, Jes Dietrich, Robin J Shattock, Frank Follmann
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice. Nature communications 15 (1) (2024)
Anja W Olsen, Ida Rosenkrands, Christina S Jacobsen, Hannah M Cheeseman, Max P Kristiansen, Jes Dietrich, Robin J Shattock, Frank Follmann
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice. Nature communications 15 (1) (2024)
Anja W Olsen, Ida Rosenkrands, Christina S Jacobsen, Hannah M Cheeseman, Max P Kristiansen, Jes Dietrich, Robin J Shattock, Frank Follmann
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice. Nature communications 15 (1) (2024)
Synne Jenum, Kristian Tonby, Corina Silvia Rueegg, Morten Rühwald, Max P Kristiansen, Peter Bang, Inge Christoffer Olsen, Kjersti Sellæg, Kjerstin Røstad, Tehmina Mustafa, Kjetil Taskén, Dag Kvale, Rasmus Mortensen, Anne Margarita Dyrhol-Riise
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. Nature communications 12 (1) (2021)